Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Meridian Bioscience Q4 EPS $0.20 Down From $0.23 YoY, Sales $65.67M Down From $76.20M YoY

Author: Benzinga Newsdesk | November 22, 2022 09:05am
Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.20 per share. This is a 13.04 percent decrease over earnings of $0.23 per share from the same period last year. The company reported $65.67 million in sales this quarter. This is a 13.82 percent decrease over sales of $76.20 million the same period last year.

Posted In: VIVO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist